Shabeeha Ranna: Improving Cancer Care Through Venous Thromboembolism Risk Assessment and Prevention
Shabeeha Ranna, Consultant Hematologist at King’s College Hospital London, shared on LinkedIn about a recent article She and her colleagues co-authored, published in BMC Cancer, adding:
“I am delighted to share our latest publication:
‘Risk Assessment and Management of Thromboembolism in Cancer Patients: A Single-Centre Retrospective Study.’
Cancer-associated thrombosis remains one of the leading causes of morbidity and mortality in patients with cancer.
Early recognition of thromboembolic risk, timely diagnosis, and evidence-based management are essential to improving patient outcomes.
This study reinforces the importance of proactive risk assessment and highlights the value of a multidisciplinary approach, bringing together oncology, haematology, pharmacy, nursing, and allied healthcare professionals to deliver optimal patient care.
I am especially proud that this project was led by a Research Intern at King’s College Hospital Dubai, demonstrating the impact that early research opportunities and strong mentorship can have in advancing clinical practice.
It has been a privilege to support a project that not only contributes to the growing evidence base in cancer-associated thrombosis but also showcases the talent and dedicationof our emerging clinical researchers.
A sincere thank you to all co-authors, mentors, and collaborators whose expertise and commitment made this work possible.
I hope these findings encourage continued efforts to improve awareness, risk stratification, and multidisciplinary management of thromboembolism in patients with cancer.”
Title: Venous thromboembolism risk assessment and prophylaxis in cancer patients
Authors: Salman Muhammad Soomar, Krish Nebhnani, Shabeeha Ranna
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 12, 2026, 21:51Sam Botchey: Orthobiologics Are Advancing but the Evidence Must Keep Pace
-
Oct 12, 2026, 21:50Serum Vitamin D, Platelet Function, and Bleeding in Primary ITP – Platelets Journal
-
Oct 12, 2026, 21:30Nika Samadzadeh Tabrizi: Looking Forward to the PACeS Trial on Anticoagulation for POAF
-
Oct 12, 2026, 21:28Michael Megaly: Does Coronary Ectasia Affect Outcomes in Acute Coronary Syndromes?
-
Oct 12, 2026, 21:25Vitor Borin P. de Souza: Think Twice Before Anticoagulating an Isolated Subsegmental PE
-
Oct 12, 2026, 20:43Jazlyn A Selvasingh: Excited to Share Our Research at AAO-HNSF 2026 in Los Angeles
-
Oct 12, 2026, 20:31Natalia Kovtun: Higher Ferritin Cutoffs Now Define Iron Deficiency
-
Oct 12, 2026, 19:39Edward Loftus: Using Low-Dose Aspirin in Pregnant Women With IBD
-
Oct 12, 2026, 19:32Shruti Sachdeva: Strengthening the Fight against Anemia